Online citations, reference lists, and bibliographies.
← Back to Search

The Role Of Chitosan In Drug Delivery

A. Fini, I. Orienti
Published 2003 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Chitosan, obtained by deacetylation of chitin, is a natural, hydrophilic, nontoxic, biocompatible, and biodegradable polysaccharide suitable for applications in pharmaceutical technology. Its role in drug delivery systems was examined by considering the chemical and biologic properties of the polymer.Chitosan is a nonbranched homopolymer formed by β-(1,4)-linked glucosamine units; hydroxyls and the amino groups are substrates for chemical modifications aimed at obtaining suitable materials for different purposes.Chitosan is soluble at acidic pH, forming gels; hydrogels are also formed in the presence of negatively charged drugs or polyanions, and represent a sustained drug release form. The bioadhesive nature of chitosan can be attributed to the same type of ionic interactions with mucosal membrane components. Mucoadhesive formulations have been developed for ocular, nasal, buccal, gastrointestinal, and vaginal drug administration. Chitosan is able to promote transmucosal absorption of small polar drugs, including peptides, inducing a transient opening of the tight junctions of the cell membrane.Due to its polymeric nature, chitosan has been widely investigated for a variety of microparticulate pharmaceutical forms. Chitosan is also a candidate for potential applications in the delivery of radiopharmaceuticals, genes and peptides.
This paper references
10.1016/S0141-8130(98)00042-7
Interactions between chitosan and α emitters: 238Pu and 241Am
Estelle Piron (1998)
Chitosan and chitosan linked to triethylene glycol glutarate or betain as tabletting excipients for the sustained release of indomethacin
K. Aiedeh (1998)
10.1080/02652040010019451
Impregnation and release of aspirin from chitosan/poly(acrylic acid) graft copolymer microspheres.
A. Nascimento (2001)
10.1016/S0378-5173(98)00416-5
Chitinosans as tableting excipients for modified release delivery systems.
P. Rege (1999)
10.1615/CRITREVTHERDRUGCARRIERSYST.V18.I5.20
Multifunctional matrices for oral peptide delivery.
A. Bernkop-Schnürch (2001)
10.1248/CPB.38.1993
Effect of interpolymer complex formation on bioadhesive property and drug release phenomenon of compressed tablet consisting of chitosan and sodium hyaluronate.
K. Takayama (1990)
Nano and microparticles as controlled drug delivery devices.
Ravi Kumar M.N.V. (2000)
10.1016/S0141-8130(00)00118-5
Chitosan as an enabling excipient for drug delivery systems. I. Molecular modifications.
S. Sabnis (2000)
10.1046/j.1365-2516.1998.440436.x
Novel delivery systems for coagulation proteins
C. Lee (1998)
10.1002/(SICI)1097-4628(19971226)66:13<2495::AID-APP12>3.0.CO;2-X
Chitosan tablets for controlled release of theophylline: Effect of polymer—drug wet or dry blending and anionic—cationic interpolymer complex
F. L. Mi (1997)
10.1016/S0169-409X(01)00180-6
Chitosan and its derivatives as intestinal absorption enhancers.
M. Thanou (2001)
10.1016/S0378-5173(99)00125-8
Chitosan microspheres prepared by spray drying.
P. He (1999)
10.1016/S0378-5173(01)00720-7
Polysaccharides in colon-specific drug delivery.
V. Sinha (2001)
10.1081/DDC-120002997
Penetration Enhancers and Ocular Bioadhesives: Two New Avenues for Ophthalmic Drug Delivery
I. P. Kaur (2002)
10.1016/S0169-409X(01)00242-3
Thermosensitive sol-gel reversible hydrogels.
Byeongmoon Jeong (2002)
10.1016/0142-9612(93)90136-P
Chitosan matrix for oral sustained delivery of ampicillin.
T. Chandy (1993)
10.1016/S0378-5173(01)00760-8
Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A.
A. M. de Campos (2001)
10.1016/S0142-9612(98)00036-2
Chitosan-chondroitin sulfate and chitosan-hyaluronate polyelectrolyte complexes: biological properties.
A. Denuzière (1998)
10.3109/02652049709006810
Chitosan microcapsules as controlled release systems for insulin.
K. Aiedeh (1997)
STUDIES ON TABLETS OF SULPHAMETHOXAZOLE USING CHITOSAN
R. Ilango (1997)
10.3109/02652049709006820
Chitosan: properties, preparations and application to microparticulate systems.
H. Kaş (1997)
10.1124/JPET.301.1.391
Intranasal delivery of morphine.
L. Illum (2002)
10.1016/B978-0-12-780950-2.50008-3
APPLICATION OF CHITIN AND CHITOSAN TO PHARMACEUTICAL PREPARATIONS
T. Nagai (1984)
10.1007/s002590000470
A phase I/IIa study on intra-articular injection of holmium-166-chitosan complex for the treatment of knee synovitis of rheumatoid arthritis
Jungsik Song (2001)
10.1016/S0378-5173(01)00985-1
Stomach-specific anti-H. pylori therapy. I: Preparation and characterization of tetracyline-loaded chitosan microspheres.
Radi Hejazi (2002)
10.1016/S0168-3659(01)00389-3
Drug physical state and drug-polymer interaction on drug release from chitosan matrix films.
S. Puttipipatkhachorn (2001)
10.1002/(SICI)1521-4184(19993)332:3<103::AID-ARDP103>3.0.CO;2-U
Synthesis of Chitosan Succinate and Chitosan Phthalate and Their Evaluation as Suggested Matrices in Orally Administered, Colon‐Specific Drug Delivery Systems
K. Aiedeh (1999)
10.1016/S0378-5173(98)00027-1
In vitro evaluation of the mucoadhesive properties of chitosan microspheres
P. He (1998)
Chitosan microspheres of diclofenac sodium, II: In vitro and in vivo evaluation.
M. Açikgöz (1995)
10.1248/BPB.22.397
Chitosan hydrogel as a base for transdermal delivery of berberine and its evaluation in rat skin.
C. J. Tsai (1999)
10.1016/S0168-3659(97)00203-4
Design of microencapsulated chitosan microspheres for colonic drug delivery.
M. L. Lorenzo-Lamosa (1998)
10.1007/978-3-0348-8757-1_22
Microparticulate drug delivery systems.
I. Genta (1999)
10.1016/S0939-6411(99)00040-5
Chitosan and chondroitin microspheres for oral-administration controlled release of metoclopramide.
A. Ganza-Gonzalez (1999)
10.1211/0022357011776441
Chitosan: some pharmaceutical and biological aspects ‐ an update
A. K. Singla (2001)
10.3109/10611860108998768
Anticancer activity of mycobacterial DNA: effect of formulation as chitosan nanoparticles.
M. Kabbaj (2001)
10.1016/S0169-409X(01)00231-9
Oral drug absorption enhancement by chitosan and its derivatives.
M. Thanou (2001)
10.1016/S0928-0987(02)00027-1
In vitro topical application and in vivo pharmacodynamic evaluation of nonivamide hydrogels using Wistar rat as an animal model.
Jia-You Fang (2002)
10.1080/026520499289068
Sustained release chitosan microspheres prepared by novel spray drying methods.
P. He (1999)
10.1016/S0142-9612(00)00134-4
Enhancing effect of chitosan on peptide drug delivery across buccal mucosa.
S. Şenel (2000)
10.1046/j.1472-765X.2002.01118.x
Fungal chitosan production and its characterization
P. Pochanavanich (2002)
10.1016/S0378-5173(98)00367-6
Evaluation of the clearance characteristics of bioadhesive systems in humans.
R. Soane (1999)
10.1016/S0378-5173(99)00030-7
Effect of chitosan on epithelial permeability and structure.
V. Dodane (1999)
10.1023/A:1012160102740
Chitosans as Absorption Enhancers for Poorly Absorbable Drugs 2: Mechanism of Absorption Enhancement
N. G. Schipper (2004)
10.1258/002367798780559220
Development of an injectable sustained-release formulation of morphine: antinociceptive properties in rats
R. Tasker (1998)
10.1016/0142-9612(92)90032-J
Chitosan cross-linked with Mo(VI) polyoxyanions: a new gelling system.
K. Draget (1992)
10.1023/A:1014220832384
The Potential of Chitosan in Enhancing Peptide and Protein Absorption Across the TR146 Cell Culture Model—An in Vitro Model of the Buccal Epithelium
A. Portero (2004)
10.1016/S0141-8130(00)00156-2
Synthesis and applications of chitosan mercaptanes as heavy metal retention agent.
G. Cárdenas (2001)
10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
Use of chitosan as a biomaterial: studies on its safety and hemostatic potential.
S. B. Rao (1997)
10.1016/S0928-0987(01)00172-5
Chitosan and its derivatives in mucosal drug and vaccine delivery.
I. M. van der Lubben (2001)
10.1016/0141-8130(93)90008-A
Hydrodynamic characterization of chitosans varying in degree of acetylation.
N. Errington (1993)
10.1016/S0169-409X(00)00136-8
Responsive polymeric delivery systems.
J. Kost (2001)
10.1248/CPB.29.3067
The use of chitin and chitosan as drug carriers.
S. Miyazaki (1981)
10.1615/CRITREVTHERDRUGCARRIERSYST.V17.I5.10
Drug targeting by surface cationization.
S. Blau (2000)
10.1016/S0378-5173(99)00334-8
Chitosan films and hydrogels of chlorhexidine gluconate for oral mucosal delivery.
S. Şenel (2000)
10.1023/A:1011996619500
Influence of Chitosan Microspheres on the Transport of Prednisolone Sodium Phosphate Across HT-29 Cell Monolayers
F. C. Mooren (2004)
10.1271/BBB.59.1901
Chitosan-derived polymer-surfactants and their micellar properties.
H. Yoshioka (1995)
10.1016/S0142-9612(99)00263-X
Drug release behavior of beads and microgranules of chitosan.
K. Gupta (2000)
10.1081/DDC-100000124
Polymeric Controlled Drug-Delivery Systems: Perspective Issues and Opportunities
M. N. R. Ravi Kumar (2001)
10.1016/S0378-5173(99)00306-3
A non-covalently cross-linked chitosan based hydrogel.
L. Noble (1999)
10.1016/S0169-409X(01)00196-X
Chemically modified chitosans as enzyme inhibitors.
A. Bernkop-Schnürch (2001)
10.1016/S0169-409X(01)00197-1
Chitosan for mucosal vaccination.
I. M. van der Lubben (2001)
10.1016/0142-9612(95)93859-C
In vitro assessment of bioadhesion for periodontal and buccal drug delivery.
I. Needleman (1995)
10.1016/S1461-5347(98)00059-5
Pharmaceutical applications of chitosan
V. Dodane (1998)
10.1016/S0168-3659(02)00084-6
Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats.
H. Tozaki (2002)
10.1016/S0168-3659(02)00077-9
Design and in vitro evaluation of a novel bioadhesive vaginal drug delivery system for clotrimazole.
C. Kast (2002)
10.2209/TDCPUBLICATION.42.243
Comparison of the activity of four chitosan derivatives in reducing initial adherence of oral bacteria onto tooth surfaces.
H. Sano (2001)
10.1023/A:1016418523014
Nasal Delivery of Insulin Using Novel Chitosan Based Formulations: A Comparative Study in Two Animal Models Between Simple Chitosan Formulations and Chitosan Nanoparticles
A. Dyer (2004)
Chitosan, a drug carrier for the 21st century : a review
W. Paul (2000)
10.1248/CPB.30.2935
Directly compressed tablets containing chitin or chitosan in addition to lactose or potato starch.
Y. Sawayanagi (1982)
10.1248/BPB.17.745
Chitosan and sodium alginate based bioadhesive tablets for intraoral drug delivery.
S. Miyazaki (1994)
10.1016/S0169-409X(98)00073-8
Intranasal insulin delivery and therapy.
Hinchcliffe (1999)
10.1016/S0378-5173(01)00755-4
In vitro and in vivo evaluations of topically applied capsaicin and nonivamide from hydrogels.
Y. Wang (2001)
10.3109/10837459709031444
Use of chitosan in compressed tablets of diclofenac sodium: inhibition of drug release in an acidic environment.
S. Sabnis (1997)
10.1016/S0142-9612(96)00167-6
In vitro and in vivo degradation of films of chitin and its deacetylated derivatives.
K. Tomihata (1997)
10.1007/BF02788043
Microencapsulation of DNA Within alginate microspheres and crosslinked chitosan membranes for in vivo application
T. Alexakis (1995)
10.1016/0141-8130(90)90015-3
Single crystals of chitosan.
N. Cartier (1990)
10.1016/0032-3861(74)90147-5
Natural chelating polymers: R. A. A. Muzzarelli Pergamon Press, Oxford, 1974, 254 pp. £4.95
E. Atkins (1974)
10.1016/S0378-5173(02)00344-7
Chitosan dispersed system for colon-specific drug delivery.
N. Shimono (2002)
10.1016/0142-9612(88)90092-0
Biological activity of chitosan: ultrastructural study.
R. Muzzarelli (1988)
10.1016/S0168-3659(98)00097-2
Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery.
F. Maclaughlin (1998)
10.1016/S0378-5173(99)00439-1
Study on glycolic acid delivery by liposomes and microspheres.
P. Perugini (2000)
10.1016/S0378-5173(99)00451-2
Chitosans as nasal absorption enhancers of peptides: comparison between free amine chitosans and soluble salts.
P. Tengamnuay (2000)
10.1016/S1461-5347(99)00199-6
Delivery of peptide and non-peptide drugs through the respiratory tract.
Davis (1999)
10.1248/CPB.33.3986
Sustained release of indomethacin from chitosan granules.
W. M. Hou (1985)
10.1016/S0168-3659(01)00294-2
Chitosan nanoparticles as delivery systems for doxorubicin.
K. Janes (2001)
10.1016/S0142-9612(01)00094-1
In vivo biocompatibility and degradability of a novel injectable-chitosan-based implant.
F. Mi (2002)
10.1023/A:1016009313548
Enteral Absorption of Insulin in Rats from Mucoadhesive Chitosan-Coated Liposomes
H. Takeuchi (2004)
10.1002/(SICI)1097-0126(199908)48:8<732::AID-PI211>3.0.CO;2-U
Chitin and chitosan as novel biotechnological materials
S. Hirano (1999)
10.1016/S0142-9612(02)00011-X
In vitro degradation of chitosan by bacterial enzymes from rat cecal and colonic contents.
H. Zhang (2002)
10.1248/CPB.46.882
Effect of several hydrophilic polymers on the permeation of morphine and salicylic acid through excised hairless rat skin.
Osamu Hosoya (1998)
10.1023/A:1011901921995
Development of Novel Chitosan Derivatives as Micellar Carriers of Taxol
A. Miwa (2004)
10.3109/03639049809089942
Chitosan: a unique polysaccharide for drug delivery.
O. Felt (1998)
10.1016/S0378-5173(00)00403-8
A novel approach to prepare tripolyphosphate/chitosan complex beads for controlled release drug delivery.
X. Shu (2000)
10.1016/S0939-6411(01)00237-5
Formulation and in vivo evaluation of chlorhexidine buccal tablets prepared using drug-loaded chitosan microspheres.
P. Giunchedi (2002)
10.1271/BBB.65.2542
Crystalline Behavior of Chitosan Organic Acid Salts
J. Kawada (2001)
10.1016/0378-5173(92)90353-4
In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers
C. Lehr (1992)
10.3109/03639049009114897
INVESTIGATION OF PROLONGED DRUG RELEASE FROM MATRIX FORMULATIONS OF CHITOSAN
A. Nigalaye (1990)
10.1080/026520499288636
Release characteristics of chitosan treated alginate beads: I. Sustained release of a macromolecular drug from chitosan treated alginate beads.
A. Sezer (1999)
10.1016/S0168-3659(01)00342-X
Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier.
S. Mitra (2001)
10.1023/A:1015812615635
A Simple Rheological Method for the in Vitro Assessment of Mucin-Polymer Bioadhesive Bond Strength
E. E. Hassan (2004)
10.1016/0142-9612(95)98278-M
Development and in vitro evaluation of chitosan-based transdermal drug delivery systems for the controlled delivery of propranolol hydrochloride.
D. Thacharodi (1995)
10.1080/107175400266623
Polyacrylamide-chitosan hydrogels: in vitro biocompatibility and sustained antibiotic release studies.
M. Risbud (2000)
10.1016/S1381-5148(00)00038-9
A review of chitin and chitosan applications
M. Kumar (2000)
10.1016/0168-3659(96)01353-3
Enhancement of the intestinal absorption of peptides and nonpeptides
B. Aungst (1996)
10.1016/S0169-409X(00)00123-X
Polysaccharide colloidal particles as delivery systems for macromolecules.
K. Janes (2001)
10.1021/BC015510C
Structural characteristics of size-controlled self-aggregates of deoxycholic acid-modified chitosan and their application as a DNA delivery carrier.
Y. Kim (2001)
10.1023/A:1011929016601
Chitosan and its use as a pharmaceutical excipient.
L. Illum (1998)
10.1016/S0378-5173(01)00915-2
Alginate/chitosan particulate systems for sodium diclofenac release.
M. González-Rodríguez (2002)
10.1016/S0378-5173(99)00365-8
Chitosan and its derivatives: potential excipients for peroral peptide delivery systems.
A. Bernkop-Schnürch (2000)
10.1016/S0928-0987(99)00032-9
Chitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancement.
N. G. Schipper (1999)
10.1046/j.1524-475X.1999.00400.x
Chitosan and chitosan sulfate have opposing effects on collagen–fibroblast interactions
M. Mariappan (1999)
10.1016/S0378-5173(02)00112-6
An in vitro evaluation of a chitosan-containing multiparticulate system for macromolecule delivery to the colon.
H. Zhang (2002)
10.1016/S0168-3659(01)00486-2
Design of biodegradable particles for protein delivery.
A. Vila (2002)
10.1016/b978-0-12-780950-2.x5001-1
Chitin, chitosan, and related enzymes
Related Enzymes (1984)
10.1016/S0142-9612(00)00116-2
Novel injectable neutral solutions of chitosan form biodegradable gels in situ.
A. Chenite (2000)
Preparation of a prolonged-release tablet formulation of diclofenac sodium. Part 1: Using chitosan.
F. Acartürk (1989)
10.1080/02652040010000415
Chitosan/gelatin microspheres prepared by modified emulsification and ionotropic gelation.
X. Shu (2001)
10.1016/S0168-3659(00)00361-8
Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency.
H. Mao (2001)
10.1023/A:1018524207224
Chitosan functional properties
R. Shepherd (2004)
10.1016/S0169-409X(01)00171-5
Chitosan as a novel nasal delivery system for vaccines.
L. Illum (2001)
10.1016/S0142-9612(00)00421-X
Thiolated polymers--thiomers: development and in vitro evaluation of chitosan-thioglycolic acid conjugates.
C. Kast (2001)
10.1016/S0378-5173(99)00196-9
Selective drug delivery to the colon using pectin:chitosan:hydroxypropyl methylcellulose film coated tablets.
G. S. Macleod (1999)
10.1093/JN/130.11.2753
Cholesterol reduction by glucomannan and chitosan is mediated by changes in cholesterol absorption and bile acid and fat excretion in rats.
C. Gallaher (2000)
10.1016/0378-5173(93)90182-F
Chitosan hydrogel as a base for semisolid drug forms
J. Knapczyk (1993)
10.1016/S0378-5173(01)00873-0
In vivo evaluation of novel hyaluronan/chitosan microparticulate delivery systems for the nasal delivery of gentamicin in rabbits.
S. T. Lim (2002)
10.1016/S0378-5173(99)00003-4
Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention.
O. Felt (1999)
10.1016/S0169-409X(01)00198-3
Chitosans for gene delivery.
G. Borchard (2001)
Use of chitosan and hydroxypropylchitosan in drug formulations to effect sustained release.
Y. Machida (1986)
10.1016/S0378-5173(02)00398-8
Binders for colon specific drug delivery: an in vitro evaluation.
V. Sinha (2002)
10.1016/S0378-5173(99)00383-X
Influence of the acid type on the physical and drug liberation properties of chitosan-gelatin sponges.
C. Leffler (2000)
10.1248/CPB.30.4464
Enhancement of Dissolution Properties of Griseofulvin from Ground Mixtures with Chitin or Chitosan
Y. Sawayanagi (1982)
10.1093/AJCN/33.4.787
A novel use of chitosan as a hypocholesterolemic agent in rats.
M. Sugano (1980)
10.1002/JPS.10149
Formulation pH modulates the interaction of insulin with chitosan nanoparticles.
Zengshuan Ma (2002)
10.3109/03639049209040896
Chitosan as a tablet binder
S. M. Upadrashta (1992)
10.1016/S0939-6411(01)00198-9
In vitro cellular accumulation of gadolinium incorporated into chitosan nanoparticles designed for neutron-capture therapy of cancer.
Futoshi Shikata (2002)
10.1016/S0378-5173(02)00060-1
Influence of different chitosan salts on the release of sodium diclofenac in colon-specific delivery.
I. Orienti (2002)
10.1016/S0142-9612(00)00183-6
Influence of the degree of acetylation on some biological properties of chitosan films.
C. Châtelet (2001)
10.1081/PDT-100100522
Mucoadhesive DL-Lactide/Glycolide Copolymer Nanospheres Coated with Chitosan to Improve Oral Delivery of Elcatonin
Y. Kawashima (2000)
10.1021/BM005649A
Two types of hydrophobic aggregates in aqueous solutions of chitosan and its hydrophobic derivative.
O. Philippova (2001)
10.1016/S0168-3659(01)00269-3
Drug permeation enhancement via buccal route: possibilities and limitations.
S. Şenel (2001)
10.1034/J.1600-051X.2000.027012904.X
Periodontal pocket clearance by gamma scintigraphy in human volunteers.
I. Needleman (2000)
10.1016/S0168-3659(99)00131-5
Effect of degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across intestinal caco-2 cell monolayers.
M. Thanou (2000)
10.1021/JS970018G
Chitosan Capsules for Colon-Specific Drug Delivery: Improvement of Insulin Absorption from the Rat Colon
H. Tozaki (1997)
10.1111/j.2042-7158.1997.tb06103.x
Bioadhesive Microspheres for Ophthalmic Administration of Acyclovir
I. Genta (1997)
10.1016/0008-6215(95)00207-A
Molecular weight manipulation of chitosan. I: Kinetics of depolymerization by nitrous acid.
G. Allan (1995)
10.1016/S0378-5173(98)00245-2
Effect of chitosan and chitosan glutamate enhancing the dissolution properties of the poorly water soluble drug nifedipine
A. Portero (1998)
10.1111/j.2042-7158.1998.tb06185.x
Polymeric Chitosan‐based Vesicles for Drug Delivery
I. Uchegbu (1998)
10.1016/S0168-3659(99)00285-0
Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan.
S. T. Lim (2000)
Biodistribution and kinetics of holmium-166-chitosan complex (DW-166HC) in rats and mice.
Y. Suzuki (1998)
Dissolution studies on tablets of ibuprofen using chitosan.
R. Ilango (1999)
10.1023/A:1018908705446
Enhancement of Nasal Absorption of Insulin Using Chitosan Nanoparticles
R. Fernández-Urrusuno (2004)
10.1080/02652040010019578
Evaluation of protein release from chitosan-alginate microcapsules produced using external or internal gelation.
G. Vandenberg (2001)
10.1080/026520499288898
Microspheres of chitosan/poly(vinylalcohol) incorporating tetrasulphonated copper (II) phthalocyanine: preparation and characterization.
J. Stolberg (1999)
10.1016/S0969-8051(00)00211-0
Preparation of 153Sm-chitosan complex for radiation synovectomy.
B. Shin (2001)
Chitosan in pharmacy and chemistry
R. Muzzarelli (2002)
10.3109/03639049409050225
Chitin and Chitosan as Disintegrants in Paracetamol Tablets
G. Ritthidej (1994)
10.1023/A:1018901302450
Chitosan as a Novel Nasal Delivery System for Peptide Drugs
L. Illum (2004)
10.1081/BIO-120004343
Encapsulation of insulin in chitosan-coated alginate beads: oral therapeutic peptide delivery.
S. Onal (2002)



This paper is referenced by
10.1080/00986440801958808
FUNCTIONALIZED CHITOSAN AND ITS USE IN PHARMACEUTICAL, BIOMEDICAL, AND BIOTECHNOLOGICAL RESEARCH
D. Enescu (2008)
10.1080/03639040701378001
Preparation, physical properties, and stability of gambogic acid-loaded micelles based on chitosan derivatives.
X. Zhu (2008)
10.2174/2211542011302010004
Recent Development in Applications of Important Biopolymer Chitosan in Biomedicine, Pharmaceuticals and Personal Care Products
G. S. Dhillon (2013)
10.3969/j.issn.2095-4344.0955
Repairing articular cartilage defects in rabbits by adipose‐derived stem cells combined with chitosan/collagen scaffold and GDF‐5
Zhenlian Wang (2018)
10.1088/0957-4484/19/14/145101
Self-assembled nanoparticles of cholesterol-modified O-carboxymethyl chitosan as a novel carrier for paclitaxel.
Yin-Song Wang (2008)
10.18502/ijaai.v19i2.2767
Immunogenicity Evaluation of Recombinant Staphylococcus aureus Enterotoxin B (rSEB) and rSEB-loaded Chitosan Nanoparticles Following Nasal Administration.
S. A. Hosseini (2020)
10.1016/j.actbio.2015.02.018
Antibacterial activity of chitosan nanofiber meshes with liposomes immobilized releasing gentamicin.
N. Monteiro (2015)
10.1533/9781845694814.5.624
Thiolated chitosans in non-invasive drug delivery
A. Bernkop-Schnürch (2008)
10.1039/B502001H
QENS investigation of the dynamics of starch saccharides.
M. Di Bari (2005)
10.1016/j.ijpharm.2011.09.011
Characterisation and stability studies of a hydrophilic decapeptide in different adjuvant drug delivery systems: a comparative study of PLGA nanoparticles versus chitosan-dextran sulphate microparticles versus DOTAP-liposomes.
A. Wieber (2011)
10.4314/TJPR.V7I3.14694
Thiolated Chitosans: Novel Polymers for Mucoadhesive Drug Delivery – A Review
S. Sreenivas (2008)
10.1016/J.EJPB.2007.03.026
Physicochemical and cell adhesion properties of chitosan films prepared from sugar and phosphate-containing solutions.
R. Bettini (2008)
Progress in the application of thiol chitosan
Yan Nan Li (2019)
10.1016/j.nano.2009.09.005
Cholesterol succinyl chitosan anchored liposomes: preparation, characterization, physical stability, and drug release behavior.
Y. Wang (2010)
10.3109/08982104.2012.700459
Characterization of fatty acid liposome coated with low-molecular-weight chitosan
H. Tan (2012)
10.1080/03639040701378001
Preparation, Physical Properties, and Stability of Gambogic Acid-Loaded Micelles Based on Chitosan Derivatives
X. Zhu (2008)
10.1039/B916139B
Flexibility and drug release features of lipid/saccharide nanoparticles
Y. Gerelli (2010)
10.1080/10717540600739872
Synthesis and Characterization of pH-Sensitive Thiol-Containing Chitosan Beads for Controlled Drug Delivery Applications
Rajadas Jayakumar (2007)
10.21608/EAJBSA.2019.37526
In Vitro Assessment of Antimicrobial Activity of Chitosan Nanoparticles Loaded with the Honeybee, Apis mellifera Venom
M. Hassan (2019)
POLYELECTROLYTE COMPLEXES OF CHITOSAN FOR PRODUCTION OF SUSTAINED RELEASE TABLETS OF BUPROPION HCL
J. Varshosaz (2015)
SYNTHESIS OF THIOLATED CHITOSANS: PROMISING POLYMERS FOR PROLONGED MUCOADHESIVE DRUG DELIVERY
(2009)
10.1117/12.776188
Determination of mechanical properties of layered materials with vector-contrast scanning acoustic microscopy by polar diagram image representation
E. T. Ahmed Mohamed (2008)
Thiolated Chitosan: Modified Advanced Generation of Mucoadhesive Polymers
K. Deepak (2012)
10.1016/S0939-6411(03)00147-4
Review articleThiolated chitosans
A. Bernkop-Schnürch (2004)
10.3109/10837450.2011.595798
Formulation and physicochemical characterization of chitosan/Acyclovir co-crystals
Ahmed N. Allam (2013)
10.2174/0929867325666180927100817
Chitosan-based Polymer Matrix for Pharmaceutical Excipients and Drug Delivery.
M. I. H. Khan (2018)
10.1211/jpp.60.9.0001
Potential prospects of chitosan derivative trimethyl chitosan chloride (TMC) as a polymeric absorption enhancer: synthesis, characterization and applications
J. Sahni (2008)
10.4137/CMRH.S40087
Femilis® 60 Levonorgestrel-Releasing Intrauterine System—A Review of 10 Years of Clinical Experience
D. Wildemeersch (2016)
10.1002/term.492
Characterization of chitosan–gelatin scaffolds for dermal tissue engineering
H. Tseng (2013)
10.1080/10717540902861267
Chitosan glutamate hydrogels with local anesthetic activity for buccal application
R. Pignatello (2009)
10.3390/ijms21145016
New Opportunity to Formulate Intranasal Vaccines and Drug Delivery Systems Based on Chitosan
R. Popescu (2020)
10.1016/B978-0-8155-2025-2.10007-1
Recent Advances in Ophthalmic Drug Delivery
J. Chang (2010)
See more
Semantic Scholar Logo Some data provided by SemanticScholar